PRESS RELEASE published on 02/09/2026 at 15:47, 7 months 3 days ago Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The The Vanguard Group, Inc. makes Form 8.3 disclosure regarding British Land Company plc, The as of 06 February 2026 The Vanguard Group, Inc. Form 8.3 Disclosure British Land Company Plc 06 February 2026
PRESS RELEASE published on 02/09/2026 at 15:45, 7 months 3 days ago Form 8.3 - The Vanguard Group, Inc.: NCC Group plc The Vanguard Group, Inc. discloses a 4.72% stake in NCC Group plc as of 06 February 2026, with 5,274 shares purchased at 1.33 GBP per share Disclosure The Vanguard Group Share Purchase Stake NCC Group Plc
PRESS RELEASE published on 02/09/2026 at 15:43, 7 months 3 days ago Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited The Vanguard Group, Inc. discloses 5.25% interest in Picton Property Income Limited's ordinary NPV shares Securities Form 8.3 Disclosure The Vanguard Group Picton Property Income Limited
PRESS RELEASE published on 02/09/2026 at 15:42, 7 months 3 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses 4.93% stake in Just Group plc as of 06 February 2026. Purchase of 18,342 securities at 2.16 GBP per unit disclosed Vanguard Group Financial Disclosure Stake Disclosure Securities Purchase Just Group Plc
PRESS RELEASE published on 02/09/2026 at 15:40, 7 months 3 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses a 3.60% stake in Spire Healthcare Group plc. Details of the acquisition include purchases of 1p ordinary shares at 2.03 GBP and 2.04 GBP per unit Financial Transactions The Vanguard Group Stake Disclosure Share Acquisition Spire Healthcare Group Plc
PRESS RELEASE published on 02/09/2026 at 15:39, 7 months 3 days ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses a 5.03% interest in Beazley plc through form 8.3. Details of securities owned and recent dealings provided Securities Form 8.3 The Vanguard Group Dealings Beazley Plc
PRESS RELEASE published on 02/09/2026 at 15:37, 7 months 3 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses a 5.95% stake in Avadel Pharmaceuticals plc as of 06/02/2026. Transactions include purchases and sales of US$0.01 ordinary shares Transactions The Vanguard Group, Inc. Stake Disclosure Avadel Pharmaceuticals Plc US$0.01 Ordinary Shares
PRESS RELEASE published on 02/09/2026 at 15:35, 7 months 3 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.08% stake in JTC plc via Form 8.3 under Rule 8.3 of the Takeover Code Takeover Code Vanguard Group Financial Disclosure Form 8.3 Disclosure JTC Plc
PRESS RELEASE published on 02/09/2026 at 15:20, 7 months 3 days ago New Star Investment Trust PLC: Net Asset Value New Star Investment Trust PLC announces unaudited Net Asset Values per Ordinary share on 31 January 2026, managed by Brompton Asset Management Limited Net Asset Value Financial Announcement New Star Investment Trust PLC Investment Trust Brompton Asset Management
PRESS RELEASE published on 02/09/2026 at 15:00, 7 months 3 days ago Gungnir Resources Inc. Announces Management And Board Changes Gungnir Resources Inc. announces changes in executive leadership and Board of Directors, including the appointment of Robert Danard as Interim CEO and new directors, reflecting commitment to growth and shareholder value Board Of Directors Shareholder Value Gungnir Resources Inc. Executive Leadership Robert Danard
Published on 09/12/2026 at 02:35, 18 hours 31 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 22 hours 6 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 23 hours 1 minute ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 23 hours 41 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 4 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 3 hours 15 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 13 hours 35 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 22 hours 51 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 22 hours 55 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 1 hour ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 1 day 14 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 14 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 2 days 1 hour ago Availability of the 2026 Interim Financial Report
